No Data
No Data
When Will Humacyte, Inc. (NASDAQ:HUMA) Become Profitable?
Humacyte, Inc. (HUMA) Laps the Stock Market: Here's Why
Express News | Humacyte and Pluristyx Announce Gene Editing Partnership to Support Biovascular Pancreas (Bvp™) Development Using Ipscs
Humacyte and Pluristyx Announce Gene Editing Partnership to Support BioVascular Pancreas (BVP) Development Using IPSCs
Express News | Humacyte Announces Planned Ind Filing in 2025 to Support First-in-Human Clinical Study of Small-Diameter Atev™ for Coronary Artery Bypass Grafting
Humacyte Announces Planned IND Filing in 2025 to Support First-In-Human Clinical Study of Small-Diameter ATEV for Coronary Artery Bypass Grafting